Drug delivery start-up Civitas attempts initial public offering; withdrawn
Just two days after closing its $55mm Series C round, Civitas Therapeutics Inc. (dry powder drug delivery systems) filed to go public.
- Medical Devices
- Drug Delivery
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.